HIGHLIGHTS
- who: Sonia Gera et al. from the Department of, National Institute of Pharmaceutical Education and Research (NIPER), GITAM School of Pharmacy, GITAM Deemed to Be University, Rudraram, Hyderabad, India have published the paper: Therapeutic Potential of Naringenin Nanosuspension: In Vitro and In Vivo Anti-Osteoporotic Studies, in the Journal: Pharmaceutics 2022, 1449 of /2022/
- what: The aim of the study was to compare the activity of naringenin nanosuspension (NRG-NS) with the NRG and standard therapeutic drug raloxifene hydrochloride (RLX). This research aimed to study the activity of NRG-NS on in_vitro osteoblast MG-63 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.